New Leaf Venture Partners as of March 31, 2016
Portfolio Holdings for New Leaf Venture Partners
New Leaf Venture Partners holds 13 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edge Therapeutics | 19.4 | $22M | 2.3M | 9.15 | |
| Versartis | 14.8 | $16M | 2.0M | 8.02 | |
| Dimension Therapeutics | 14.6 | $16M | 2.1M | 7.83 | |
| Oxford Immunotec Global | 12.3 | $14M | 1.4M | 9.91 | |
| Wave Life Sciences (WVE) | 9.8 | $11M | 784k | 13.88 | |
| Dynavax Technologies (DVAX) | 8.6 | $9.5M | 496k | 19.24 | |
| Alder Biopharmaceuticals | 5.5 | $6.1M | 248k | 24.49 | |
| Sage Therapeutics (SAGE) | 4.1 | $4.6M | 143k | 32.06 | |
| Dermira | 3.4 | $3.8M | 184k | 20.68 | |
| Marinus Pharmaceuticals | 3.4 | $3.8M | 705k | 5.38 | |
| Chimerix (CMRX) | 2.7 | $3.0M | 583k | 5.11 | |
| Incyte Corporation (INCY) | 1.1 | $1.2M | 16k | 72.50 | |
| Karyopharm Therapeutics (KPTI) | 0.1 | $109k | 12k | 8.92 |
